Skip to content

Noradrenergic Activity, Cognition and Major Depressive Disorder

Influences on Noradrenergic Activity for Cognition in Patients With Major Depressive Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02470026
Acronym
YohCog
Enrollment
131
Registered
2015-06-12
Start date
2014-06-30
Completion date
2018-10-31
Last updated
2019-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder, Early Life Trauma

Brief summary

This study investigates influences of nordadrenergic activity on cognition in patients with major depression regarding influences of early life stress.

Detailed description

Stress plays a major role in the development and maintenance of major depression disorder. Indeed, various studies demonstrated maladaptive changes in physiological stress regulation systems of depressive patients, i.e. in the hypothalamus-pituitary-adrenal axis and the locus coeruleus-noradrenergic system. On a central level, changes of the locus coeruleus-noradrenergic system have been demonstrated.This seems to be the case especially in depressive patients with early life traumata. Comparable to the hypothalamus-pituitary-adrenal axis, the locus coeruleus-noradrenergic system influences not only the physiological stress response, but has also central influence with effects on cognitive functions. Indeed, noradrenergic effects on cognitive functions such as attention, learning and memory have been demonstrated in healthy individuals. Even though deficits in cognitive domains are core symptoms of major depression, the relationship of the noradrenergic system and cognitive processes has rarely been investigated so far. In this project, the investigators will examine noradrenergic influences via administration of the alpha2-receptor blocker yohimbine on cognitive and emotionally relevant processes in depressive patients and controls. Additionally, the investigators will examine the influence of early life traumata on these relationships. Thus, the investigators will examine participants with and without major depression and with and without early life stress. Results of this study will improve the understanding of cognitive dysfunctions associated with the noradrenergic system in patients with major depression.

Interventions

single low dose treatment

DRUGplacebo

single control treatment

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* diagnosis of major depression * experience of early life trauma

Exclusion criteria

* severe illness * Alzheimer´s * schizophrenia * bipolar disorder * control group: - diagnosis of major depression/ experience of early life trauma

Design outcomes

Primary

MeasureTime frameDescription
behavioral responses in two different conditions of noradrenergic stimulation2,5 hrsreaction times and error scores (computer tasks)
physiological responses in two different conditions of noradrenergic stimulation2,5 hrsphysiological recordings, saliva samples

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026